See every side of every news story
Published loading...Updated

Camden National: Q2 Earnings Snapshot

UNITED STATES, JUL 30 – Penumbra, Inc. reported improved profitability and operational efficiency driven by higher thrombectomy product sales and favorable product mix, reflecting growing demand in the U.S. market.

  • A July 29 release reports total revenue of $339.5 million, with U.S. thrombectomy revenue at $188.5 million, reflecting regional growth and decline.
  • Market demand and productivity improvements powered favorable product mix and productivity improvements boosted gross margin ex-impairment.
  • Profitability improved with net income of $45.3 million, yielding a 13.3% margin, and adjusted EBITDA reached $61.4 million, representing an 18.1% margin.
  • A webcast will follow the earnings announcement, with Todd DeBonis, President and CEO, and CFO Haley Aman hosting a conference call at 2:00 p.m. Pacific Time.
  • As the company enters the second half of 2025, management expects gross margin expansion supported by favorable product mix and productivity improvements.
Insights by Ground AI
Does this summary seem wrong?

84 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 65% of the sources are Center
65% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

mammothtimes.com broke the news in on Monday, July 28, 2025.
Sources are mostly out of (0)

Similar News Topics